Structure-activity analysis of macrocyclic peptide deformylase inhibitors identified optimal ring sizes for potent enzyme inhibition, advancing this novel antibiotic mechanism toward drug-like compounds.
Key findingRing size optimization of macrocyclic peptide deformylase inhibitors identified the most potent macrocycle dimensions, with X-ray crystallography conf
What the researchers found
Ring size optimization of macrocyclic peptide deformylase inhibitors identified the most potent macrocycle dimensions, with X-ray crystallography confirming optimal binding geometry — advancing this bacteria-selective antibiotic mechanism.
Why it matters
Advances understanding of cyclic-peptides, infection, peptide-design with translational implications.
How the study worked
in-vitro study examining cyclic-peptides and infection.
What this study cannot tell us
Study-specific limitations apply; see abstract for details.
How to read the evidence
preliminary evidence from in-vitro study design.
When this study was published
Published in 2004.
The bigger picture
Contributes to the growing body of peptide research with implications for clinical development and therapeutic applications.
Questions still open
- Further research needed to confirm and extend these findings.
- Clinical translation and safety need evaluation.
- Optimal dosing and delivery require characterization.
Common questions
What was the main focus of this study?
What was discovered?
Read the original research
Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Journal of medicinal chemistry, 47(20), 4941-9
Citation
Hu, Xubo; Nguyen, Kiet T; Jiang, Vernon C; Lofland, Denene; Moser, Heinz E; Pei, Dehua. (2004). Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.. Journal of medicinal chemistry, 47(20), 4941-9.